TheraRadar
← Back
Data updated: Mar 29, 2026

MANKIND PHARMA

CardiovascularNeurologyRespiratory
Generics

MANKIND PHARMA is a generic drug manufacturer focused on Cardiovascular, Neurology, Respiratory.

2001
Since
57
Drugs
-
Trials
537
Approved (2yr)

Key Drugs

No active drugs

Top Drug Revenues Pro

Loading...

Revenue Over Time Pro

Loading...

Recent Activity

TELMISARTAN AND HYDROCHLOROTHIAZIDE 2026-02-17
Labeling
TELMISARTAN AND HYDROCHLOROTHIAZIDE 2026-02-17
Labeling
TELMISARTAN AND HYDROCHLOROTHIAZIDE 2026-02-17
Labeling
TELMISARTAN AND HYDROCHLOROTHIAZIDE 2026-02-17
Labeling
GLYCOPYRROLATE 2026-02-10
Labeling
GLYCOPYRROLATE 2026-02-06
Labeling
TICAGRELOR 2026-02-06
BUMETANIDE 2026-02-05
SEC Filings Pro
Loading...

Therapeutic Areas

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Cardiovascular 46%
11 drugs
Neurology 17%
4 drugs
Respiratory 17%
4 drugs
Infectious Disease 13%
3 drugs
Ophthalmology 7%
1 drugs Phase 3: 1

Pipeline Forecast

Loading...

Upcoming Trial Milestones Pro

Loading...

Patent Cliff Pro

Loading...

Competitors by Therapeutic Area

Novartis big-pharma
Cardiovascular, Ophthalmology, Respiratory
GE HEALTHCARE specialty
Infectious Disease, Neurology, Cardiovascular, Respiratory
Baxter specialty
Infectious Disease, Cardiovascular, Ophthalmology
AbbVie big-pharma
Neurology, Infectious Disease, Ophthalmology
LEDERLE big-pharma
Infectious Disease, Cardiovascular, Neurology, Respiratory